Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
16.01. | Cellular Origins, Cytiva Partner on Robotic Mfg. Capabilities for CGTs | ||
16.01. | Caris Life Sciences and Ontada Partner to Advance Oncology Research | ||
16.01. | Emmes Group Appoints Chief Commercial Officer of Emmes Biopharma | ||
16.01. | Charles River Integrates Akron Bio's CSS Line of Liquid Cytokines | ||
15.01. | Navin Molecular to Expand Process R&D Capacity | ||
15.01. | Piramal Pharma Makes Progress Toward Sustainability Goals | ||
15.01. | Lyndra, Thermo Fisher Partner to Bring Long-Acting Oral Therapies to Market | ||
15.01. | Regenxbio, Nippon Shinyaku Partner for MPS II, MPS I Gene Therapies | ||
15.01. | Freudenberg Medical Names New CEO | ||
14.01. | CS Analytical Granted U.S. Department of Agriculture BSL-2 Certification | ||
14.01. | Moffitt Cancer Center Partners with Cryoport | ||
14.01. | Grifols Awarded $21M Michael J. Fox Foundation Grant | ||
14.01. | Terumo BCT, FUJIFILM Irvine Scientific Partner on T Cell Expansion Solution | ||
14.01. | Enhanc3D Genomics Launches Suite of Integrated Multi-Omics Solutions | ||
14.01. | Sapio Sciences Upgrades Informatics Platform with Release 24.12 | ||
14.01. | Vetter to Introduce New V-OVS Syringe Closure System | ||
14.01. | Hikma Partners with Emergent for the Sale of KLOXXADO in the U.S. & Canada | ||
14.01. | Touchlight's Hampton, UK Facility Receives GMP Certification from MHRA | ||
14.01. | Cube Biotech Acquires IBA Lifesciences | ||
14.01. | BioMedX Launches Collaboration with Daiichi Sankyo to Explore New Approaches in Cancer Treatment | ||
13.01. | Quadria Capital Invests $100M in Aragen to Expand CRDMO Services | ||
13.01. | Biohaven & Merus Team Up to Develop Novel Bispecific ADC Therapies | ||
13.01. | GSK Agrees to Acquire IDRx | ||
13.01. | Alcami Announces CEO Transition | ||
13.01. | AbbVie, Simcere Zaiming Partner to Develop Trispecific Antibody in Multiple Myeloma |